BACKGROUND: Leukoreduction of labile blood components dramatically decreases the frequency of minor, intermediate, and severe adverse events (AEs), referred to as acute transfusion reactions (ATRs), especially after transfusion of platelet components (PCs). The pathophysiology of AEs may result from...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!